直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Inaugural IPR Decision Provides Insight for Patent Challengers Deciding Between IPR and District Court Litigation

December 13, 2013

Authored and Edited by Anthony C. Tridico, Ph.D.

The recent Garmin decision raises strategic implications for litigants deciding whether to pursue inter partes review (IPR)  or district court litigation. The Board in Garmin upheld petitioner’s claim of unpatentability of claims 10, 14, and 17 of U.S. Patent No. 6,778,074 as obvious under 35 U.S.C. § 103 in view of a three-reference combination and separately under a four-reference combination. The question becomes—would the same result have occurred if the case had proceeded before a district court? Not likely for at least two reasons.

Higher Standard in Federal Courts: IPR applies a lower evidentiary standard than district court litigation; the petition is reviewed under the “preponderance of evidence” standard, with the burden placed on the petitioner. In contrast, petitioners in a district court proceeding must provide clear and convincing evidence that one or more of the claims are invalid which presents a much higher bar to challengers. Another key difference: The district court, but not the USPTO, is required to presume that the patent is valid.

Federal Court Judges and Jury Typically Lack Technical Expertise: District court judges typically lack technical and/or patent expertise in contrast with USPTO administrative patent judges, who all have extensive patent experience. That distinction may be significant. An IPR panel is more likely to invalidate claims based on a complex multi-reference obviousness combination simply by being more familiar with the subject matter or the types of arguments typically presented by Examiners during patent examination. Federal court judges and/or juries, on the other hand, are less likely to invalidate claims under a complex obviousness combination because they tend to lack the specialized knowledge of patent practitioners. With the added presumption of validity requirement, there is a much lower risk of invalidation in district court proceedings based on a three-reference combination or four-reference combination obviousness challenge.

Garmin provides some interesting considerations to patent challengers contemplating multi-reference obviousness claims. IPR may provide a more efficient, less expensive alternative to proceeding in the district court where invalidation based on a three-reference combination or four-reference combination obviousness challenge is less likely.

Tags

administrative patent judge (APJ), District Court, Garmin v. Cuozzo, invalidity

Contacts

Anthony C. Tridico, Ph.D.
Partner
Washington, DC
+1 202 408 4173
Email

Copyright © 2013 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP